APA (7th ed.) Citation

B, C., JC, S. E. S., H, N., N, S., F, B., G, P., . . . L, D. (2025). In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis. Nature communications, 16(1), 5533. https://doi.org/10.1038/s41467-025-60224-3

Chicago Style (17th ed.) Citation

B, Chaves, et al. "In Vitro Morphological Profiling of T Cells Predicts Clinical Response to Natalizumab Therapy in Patients with Multiple Sclerosis." Nature Communications 16, no. 1 (2025): 5533. https://doi.org/10.1038/s41467-025-60224-3.

MLA (9th ed.) Citation

B, Chaves, et al. "In Vitro Morphological Profiling of T Cells Predicts Clinical Response to Natalizumab Therapy in Patients with Multiple Sclerosis." Nature Communications, vol. 16, no. 1, 2025, p. 5533, https://doi.org/10.1038/s41467-025-60224-3.